SitesBLAST
Comparing WP_009490181.1 NCBI__GCF_000313915.1:WP_009490181.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
P24207 Phenylalanine-specific permease; Phenylalanine:H(+) symporter PheP from Escherichia coli (strain K12) (see 3 papers)
41% identity, 98% coverage: 2:442/448 of query aligns to 15:453/458 of P24207
- R26 (= R13) mutation R->G,S,Q: Strong decrease in phenylalanine transport activity.
- P54 (= P41) mutation to A: 50% of wild-type phenylalanine transport activity.; mutation to G: No change in phenylalanine transport activity.; mutation to L: 26% of wild-type phenylalanine transport activity.
- F87 (= F74) mutation to L: No effect on phenylalanine transport activity.
- F90 (≠ L77) mutation to L: 65% of wild-type phenylalanine transport activity.
- Y92 (≠ H79) mutation to L: 41% of wild-type phenylalanine transport activity.
- Y94 (= Y81) mutation to L: 69% of wild-type phenylalanine transport activity.
- W95 (≠ L82) mutation to L: 10% of wild-type phenylalanine transport activity.
- F98 (≠ R85) mutation to L: No effect on phenylalanine transport activity.
- F101 (= F88) mutation to L: 38% of wild-type phenylalanine transport activity.
- W105 (= W92) mutation to L: 39% of wild-type phenylalanine transport activity.
- Y107 (= Y94) mutation to L: No effect on phenylalanine transport activity.
- W108 (= W95) mutation to L: 71% of wild-type phenylalanine transport activity.
- F111 (≠ W98) mutation to L: 60% of wild-type phenylalanine transport activity.; mutation to Y: Enables the transport of tryptophan to almost the same steady-state level as that of phenylalanine.
- E118 (≠ D105) mutation E->G,L,V,N: Loss of activity.
- K168 (= K155) mutation K->L,R: Strong decrease in phenylalanine transport activity.; mutation to N: Loss of activity.
- E226 (= E216) mutation E->A,Q,K,R,W: Loss of activity.
- R252 (= R242) mutation R->D,E,F,W,P: Loss of activity.
- P341 (= P331) mutation to A: 5% of wild-type phenylalanine transport activity.; mutation P->G,Q,K,R: Loss of activity.; mutation to S: 3% of wild-type phenylalanine transport activity.; mutation to T: 17% of wild-type phenylalanine transport activity.
- P442 (= P431) mutation to A: 46% of wild-type phenylalanine transport activity.; mutation to G: 52% of wild-type phenylalanine transport activity.; mutation to L: 43% of wild-type phenylalanine transport activity.
P15993 Aromatic amino acid transport protein AroP; Aromatic amino acid:H(+) symporter AroP; General aromatic amino acid permease; General aromatic transport system from Escherichia coli (strain K12) (see paper)
41% identity, 99% coverage: 4:448/448 of query aligns to 9:449/457 of P15993
- Y103 (≠ W98) Key residue for tryptophan transport; mutation to F: Decreases tryptophan transport to less than 50% of wild-type levels and reduces the ability of tryptophan to inhibit phenylalanine transport from 95 to 62%.
Q88CZ8 L-histidine transporter HutT from Pseudomonas putida (strain ATCC 47054 / DSM 6125 / CFBP 8728 / NCIMB 11950 / KT2440) (see paper)
42% identity, 98% coverage: 4:441/448 of query aligns to 5:445/467 of Q88CZ8
- T27 (= T26) mutation T->A,S: Retains 60% of wild-type activity.; mutation to N: Retains 20% of wild-type activity.
- E98 (≠ C97) mutation to A: Retains 80% of wild-type activity.
- K156 (= K155) mutation K->A,Q: Retains less than 10% of wild-type activity.; mutation to R: Retains 40% of wild-type activity.
- F212 (= F210) mutation F->A,Q: Loss of activity.; mutation to Y: No change in activity.
- E218 (= E216) mutation E->A,Q: Loss of activity.; mutation to D: Retains 70% of wild-type activity.
P46349 Gamma-aminobutyric acid permease; GABA permease; 4-aminobutyrate permease; Gamma-aminobutyrate permease; Proline transporter GabP from Bacillus subtilis (strain 168) (see paper)
37% identity, 100% coverage: 2:448/448 of query aligns to 4:454/469 of P46349
- G33 (≠ A31) mutation to D: Lack of activity.
- G42 (= G40) mutation to S: Lack of activity.
- G301 (≠ A301) mutation to V: Lack of activity.
- G338 (≠ S338) mutation to E: Lack of activity.
- F341 (≠ V341) mutation to S: Lack of activity.
- G414 (≠ L412) mutation to R: Lack of activity.
P25737 Lysine-specific permease LysP; Lysine transporter LysP; Trigger transporter LysP from Escherichia coli (strain K12) (see 2 papers)
37% identity, 87% coverage: 6:395/448 of query aligns to 13:413/489 of P25737
- Y102 (= Y94) mutation to L: Retains 4% of wild-type lysine uptake activity. Increases the capacity to inhibit CadC in the presence of lysine.
- W106 (= W98) mutation to L: Retains 20% of wild-type lysine uptake activity. Increases the capacity to inhibit CadC in the presence of lysine.
- K163 (= K155) mutation to A: Retains 24% of wild-type lysine uptake activity. Increases the capacity to inhibit CadC in the presence of lysine.
- F216 (= F210) mutation to L: Retains 13% of wild-type lysine uptake activity. Increases the capacity to inhibit CadC in the presence of lysine.
- E222 (= E216) mutation to A: Abolishes lysine uptake. Strongly inhibits CadC.
- E230 (= E224) mutation to V: Abolishes lysine uptake. Shows significant less inhibition of CadC.
- D275 (≠ N261) Essential for the stimulus-dependent interaction with CadC; mutation to A: Retains 88% of wild-type lysine uptake activity, but can hardly inhibit CadC. Cannot interact with CadC; when associated with A-278.
- D278 (= D264) Essential for the stimulus-dependent interaction with CadC; mutation to A: Retains 88% of wild-type lysine uptake activity, but can hardly inhibit CadC. Cannot interact with CadC; when associated with A-275.
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
- 438 E→A: Retains 14% of wild-type lysine uptake activity. Is unable to inhibit CadC.
- 443 D→A: Retains 11% of wild-type lysine uptake activity. Is unable to inhibit CadC.
- 446 D→A: Retains 13% of wild-type lysine uptake activity. Is unable to inhibit CadC.
P04817 Arginine permease CAN1; Canavanine resistance protein 1 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) (see paper)
30% identity, 100% coverage: 1:446/448 of query aligns to 79:549/590 of P04817
- P113 (≠ S35) mutation to L: In CAN1-343; confers citrulline transport activity in GAP1-deleted cells.
- P148 (≠ L69) mutation to L: In CAN1-337; confers citrulline transport activity in GAP1-deleted cells and leads to sensitivity to L-glutamic acid alpha-hydroxamate, alpha-aminoisobutyrate, 3-chloro-L-alanine, L-ethionine, L-allylglycine, and D-histidine, but not sensitivity to L-aspartic acid alpha-hydroxamate or p-fluoro-L-phenylalanine.
- V149 (≠ D70) mutation to F: In CAN1-315; confers citrulline transport activity in GAP1-deleted cells.
- S152 (= S73) mutation to F: In CAN1-342; confers citrulline transport activity in GAP1-deleted cells.
- Y173 (= Y94) mutation to D: In CAN1-306; confers citrulline transport activity in GAP1-deleted cells.; mutation to H: In CAN1-327; confers citrulline transport activity in GAP1-deleted cells.
- G308 (= G223) mutation to A: In CAN1-341; confers citrulline transport activity in GAP1-deleted cells.
- P313 (= P228) mutation to S: In CAN1-329; confers citrulline transport activity in GAP1-deleted cells and leads to sensitivity to L-glutamic acid alpha-hydroxamate, alpha-aminoisobutyrate, 3-chloro-L-alanine, L-ethionine, L-allylglycine, and D-histidine, L-aspartic acid alpha-hydroxamate and p-fluoro-L-phenylalanine.
- TS 354:355 (vs. gap) mutation Missing: In CAN1-318; confers citrulline transport activity in GAP1-deleted cells.
- Y356 (vs. gap) mutation to H: In CAN1-340; confers citrulline transport activity in GAP1-deleted cells.; mutation to N: In CAN1-339; confers citrulline transport activity in GAP1-deleted cells.
- W451 (≠ L359) mutation to C: In CAN1-328; confers citrulline transport activity in GAP1-deleted cells.; mutation to L: In CAN1-316; confers citrulline transport activity in GAP1-deleted cells.; mutation to S: In CAN1-335; confers citrulline transport activity in GAP1-deleted cells.
- F461 (≠ L369) mutation to S: In CAN1-307; confers citrulline transport activity in GAP1-deleted cells.
Q9URZ4 Cationic amino acid transporter 1 from Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast) (see paper)
32% identity, 84% coverage: 6:382/448 of query aligns to 80:465/587 of Q9URZ4
Sites not aligning to the query:
- 29 modified: Phosphoserine
- 30 modified: Phosphoserine
- 37 modified: Phosphoserine
P19145 General amino-acid permease GAP1 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) (see 3 papers)
30% identity, 87% coverage: 2:391/448 of query aligns to 82:483/602 of P19145
- A297 (≠ T213) mutation to V: Impairs basic amino-acids transport and regulation by these amino-acids.
Sites not aligning to the query:
- 76 modified: Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
P48813 High-affinity glutamine permease from Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) (see paper)
28% identity, 87% coverage: 1:391/448 of query aligns to 140:542/663 of P48813
Sites not aligning to the query:
- 132 modified: Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
Q03770 SPS-sensor component SSY1; Amino-acid permease homolog SSY1 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) (see paper)
26% identity, 85% coverage: 6:388/448 of query aligns to 277:736/852 of Q03770
- T382 (≠ G110) mutation T->H,L: Constitutively active, up-regulates amino acid permease transcription in response to subthreshold concentrations of amino acids.; mutation to K: In SSY1-102; constitutively active, up-regulates amino acid permease transcription in the absence of amino-acids.; mutation to R: Constitutively active, up-regulates amino acid permease transcription in the absence of amino acids.
P30825 High affinity cationic amino acid transporter 1; CAT-1; CAT1; Ecotropic retroviral leukemia receptor homolog; Ecotropic retrovirus receptor homolog; Solute carrier family 7 member 1; System Y+ basic amino acid transporter from Homo sapiens (Human) (see paper)
22% identity, 77% coverage: 2:344/448 of query aligns to 24:398/629 of P30825
- N226 (≠ I180) modified: carbohydrate, N-linked (GlcNAc...) asparagine
6f34A Crystal structure of a bacterial cationic amino acid transporter (cat) homologue bound to arginine. (see paper)
21% identity, 50% coverage: 193:415/448 of query aligns to 211:426/458 of 6f34A
Sites not aligning to the query:
- binding arginine: 40, 42, 43, 44, 115, 116, 119
- binding cholesterol: 201, 202
- binding : 28, 30, 31, 34, 178, 179, 186, 187, 190, 194
P60061 Arginine/agmatine antiporter from Escherichia coli (strain K12) (see 3 papers)
24% identity, 71% coverage: 78:394/448 of query aligns to 77:387/445 of P60061
- Y93 (= Y94) mutation to L: Greatly decreased Arg uptake into liposomes.
- A96 (vs. gap) binding agmatine; binding L-arginine
- C97 (= C97) binding agmatine
- N101 (≠ V101) binding agmatine; mutation to A: Vmax for Arg-Agm exchange 1% of wild-type, KM increases 3-fold.; mutation to D: Nearly wild-type Arg-Agm exchange.
- M104 (≠ S104) binding agmatine; mutation to A: 30% decreased affinity for Arg, 50% decreased affinity for Agm.
- W202 (≠ F210) binding L-arginine; mutation to L: Halves Arg uptake into liposomes.
- S203 (= S211) binding agmatine
- I205 (≠ T213) binding agmatine; binding L-arginine; mutation to A: About wild-type affinity for Arg and Agm.
- W293 (≠ T305) binding agmatine; mutation W->C,H,L: Loss of Arg-Agm exchange.; mutation W->F,Y: Less than 20% Arg-Agm exchange activity. Vmax 15% of wild-type rate.
- S357 (= S364) binding L-arginine; mutation to A: 20% decreased affinity for Arg, 40% decrease affinity for Agm.
Sites not aligning to the query:
- 23 binding agmatine; binding L-arginine
- 26 binding L-arginine
P60063 Arginine/agmatine antiporter from Escherichia coli O157:H7 (see 3 papers)
24% identity, 71% coverage: 78:394/448 of query aligns to 77:387/445 of P60063
- Y87 (≠ F88) mutation to A: Markedly reduced binding affinity for Agm but not for Arg. 50% Agm antiport.
- Y93 (= Y94) mutation to A: Reduced binding affinity for Arg, no binding to Agm. 25% Agm antiport.; mutation to K: Almost no binding to both Arg and Agm. 5% Agm antiport.
- A96 (vs. gap) binding L-arginine
- C97 (= C97) binding L-arginine
- N101 (≠ V101) binding L-arginine
- W202 (≠ F210) Periplasmic (proximal) gate; binding L-arginine
- I205 (≠ T213) binding L-arginine
- GVESA 206:210 (≠ GVELV 214:218) Helix-breaking GVESA motif TM6
- E208 (= E216) mutation E->A,D: 5-10% Agm antiport.
- W293 (≠ T305) binding L-arginine
- F337 (≠ I346) mutation to A: Severely decreased antiport.
- S357 (= S364) binding L-arginine
- Y365 (≠ F370) mutation to A: Markedly weakened binding to Arg but not to Agm. 5% Agm antiport.
Sites not aligning to the query:
- 22 N→A: No change in antiport activity, 6-fold higher affinity for Arg.
- 23 binding L-arginine
- 25:27 Helix-breaking GSG motif TM1
- 26 binding L-arginine; S→K: 5% Agm antiport.
- 27 binding L-arginine
- 74 Y→A: 50% antiport activity at pH 6.0, 10-fold higher than wild-type antiport activity at pH 7.5, i.e. loss of pH-dependence of substrate transport. No change in binding of Arg or Agm.; mutation Y->C,H,L,M,Q,S: Loss of pH-dependence of substrate transport.; Y→F: Approximately wild-type antiport.
5j4nA Crystal structure of the l-arginine/agmatine antiporter adic in complex with agmatine at 2.6 angstroem resolution (see paper)
24% identity, 71% coverage: 78:394/448 of query aligns to 73:383/437 of 5j4nA
Sites not aligning to the query:
5oqtA Crystal structure of a bacterial cationic amino acid transporter (cat) homologue (see paper)
21% identity, 50% coverage: 193:415/448 of query aligns to 209:424/456 of 5oqtA
Sites not aligning to the query:
- binding alanine: 38, 40, 41, 42
- binding : 24, 26, 28, 29, 32, 176, 177, 184, 188, 192
3l1lA Structure of arg-bound escherichia coli adic (see paper)
24% identity, 65% coverage: 78:366/448 of query aligns to 71:342/423 of 3l1lA
Sites not aligning to the query:
8xxiA Structure of y+lat1 bound with leu
21% identity, 88% coverage: 2:393/448 of query aligns to 1:384/465 of 8xxiA
8xyjA Structure of y+lat1 bound with lys
21% identity, 88% coverage: 2:393/448 of query aligns to 1:384/459 of 8xyjA
P0AAE8 Cadaverine/lysine antiporter from Escherichia coli (strain K12) (see paper)
22% identity, 81% coverage: 87:448/448 of query aligns to 82:430/444 of P0AAE8
- Y89 (= Y94) mutation to L: Strong decrease in both cadaverine excretion and cadaverine uptake. 10-fold increase in Km for cadaverine for cadaverine uptake and 5-fold increase in Km for cadaverine for cadaverine excretion.
- Y90 (≠ W95) mutation to L: Strong decrease in both cadaverine excretion and cadaverine uptake.
- Y107 (= Y112) mutation to L: Strong decrease in cadaverine uptake.
- C125 (≠ L130) mutation to S: Does not affect cadaverine excretion and cadaverine uptake.
- Y174 (≠ V181) mutation to L: Moderate decrease in cadaverine uptake.
- D185 (= D190) mutation to N: Moderate decrease in cadaverine uptake.
- C196 (≠ A208) mutation to S: Moderate decrease in both cadaverine excretion and cadaverine uptake.
- E204 (= E216) mutation to Q: Strong decrease in both cadaverine excretion and cadaverine uptake. 22-fold increase in Km for cadaverine for cadaverine uptake and 6-fold increase in Km for cadaverine for cadaverine excretion.
- Y235 (= Y247) mutation to L: Strong decrease in both cadaverine excretion and cadaverine uptake. 23-fold increase in Km for cadaverine for cadaverine uptake and 7-fold increase in Km for cadaverine for cadaverine excretion.
- Y246 (≠ Q258) mutation to L: Moderate decrease in both cadaverine excretion and cadaverine uptake.
- C282 (≠ A294) mutation to S: Moderate decrease in both cadaverine excretion and cadaverine uptake.
- R299 (≠ G311) mutation to A: Strong decrease in cadaverine excretion but not in cadaverine uptake.
- D303 (= D315) mutation to N: Strong decrease in both cadaverine excretion and cadaverine uptake. 24-fold increase in Km for cadaverine for cadaverine uptake and 9-fold increase in Km for cadaverine for cadaverine excretion.
- Y310 (≠ F322) mutation to L: Moderate decrease in both cadaverine excretion and cadaverine uptake.
- Y366 (≠ F382) mutation to L: Strong decrease in cadaverine uptake. 15-fold increase in Km for cadaverine for cadaverine uptake.
- Y368 (≠ K384) mutation to L: Strong decrease in cadaverine uptake.
- C370 (≠ T386) mutation to S: Strong decrease in both cadaverine excretion and cadaverine uptake.
- E377 (≠ K397) mutation to Q: Moderate decrease in both cadaverine excretion and cadaverine uptake.
- C389 (≠ F409) mutation to S: Moderate decrease in both cadaverine excretion and cadaverine uptake.
- C394 (≠ I414) mutation to S: Moderate decrease in both cadaverine excretion and cadaverine uptake.
- C397 (= C417) mutation to S: Moderate decrease in both cadaverine excretion and cadaverine uptake.
- E408 (≠ A426) mutation to Q: Moderate decrease in cadaverine uptake.
- Y423 (= Y441) mutation to L: Strong decrease in both cadaverine excretion and cadaverine uptake.
Sites not aligning to the query:
- 12 C→S: Does not affect cadaverine excretion and cadaverine uptake.
- 41 W→L: Moderate decrease in cadaverine uptake.
- 43 W→L: Strong decrease in cadaverine uptake.
- 55 Y→L: Moderate decrease in both cadaverine excretion and cadaverine uptake.
- 57 Y→L: Strong decrease in cadaverine uptake.
- 73 Y→L: Strong decrease in both cadaverine excretion and cadaverine uptake. 9-fold increase in Km for cadaverine for cadaverine uptake and 10-fold increase in Km for cadaverine for cadaverine excretion.
- 76 E→Q: Moderate decrease in both cadaverine excretion and cadaverine uptake.
Query Sequence
>WP_009490181.1 NCBI__GCF_000313915.1:WP_009490181.1
MSQEKLERGLSNRHVQLISIGGAIGTGLFLASGKSIAIAGPSVLLAYMIVGMFVFFIMRS
LGELLLANLDCHSFVELAHQYLGRRWAFVTGWTYWFCWITVAMSDLTAVGMYMRYWFPHL
PQWIPALLMLLFLMALNLLSVKLFGEIEFWLALIKILAIVALIGVGLYMIFTHHKLENGI
VASFANLYQDGGFFPHGFSGFILSFQLAVFSFTGVELVGLTAGETQDPEKTLPKAINNIP
VRILLFYVGSLAVIMAVQPWNIIDPTQSPFVTVFSSIGIAAAASIINFVVLSSAASACNS
ALFSTSRMLYGLAKDDNAPKTFAKLNKNSTPAMALLMSSVVVGITIVLNYVMPEGVFSLI
SGISTVCFLFIWTIIVICHMKFLKQTKDEDRPKFRLKGAKVINILSLIFLALIIVICAVL
ESTRIALFITPIWFIALLIIYQVKFKEQ
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory